Literature DB >> 25728791

Quantitative proteomics reveals a novel role of karyopherin alpha 2 in cell migration through the regulation of vimentin-pErk protein complex levels in lung cancer.

Chun-I Wang1, Chih-Liang Wang1, Yi-Cheng Wu1, Hsiang-Pu Feng1, Pei-Jun Liu1, Yu-Sun Chang1, Jau-Song Yu1, Chia-Jung Yu1.   

Abstract

Karyopherin alpha 2 (KPNA2) is overexpressed in various human cancers and is associated with cancer invasiveness and poor prognosis. Herein, to understand the essential role of KPNA2 protein complexes in cancer progression, we applied stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomic strategy combined with immunoprecipitation (IP) to investigate the differential KPNA2 protein complexes in lung adenocarcinoma cell lines with different invasiveness potentials. We found that 64 KPNA2-interaction proteins displayed a 2-fold difference in abundance between CL1-5 (high invasiveness) and CL1-0 (low invasiveness) cells. Pathway map analysis revealed that the formation of complexes containing KPNA2 and cytoskeleton-remodeling-related proteins, including actin, beta tubulin, tubulin heterodimers, vimentin, keratin 8, keratin 18, and plectin, was associated with cancer invasiveness. IP demonstrated that the levels of KPNA2-vimentin-pErk complexes were significantly higher in CL1-5 cells than in CL1-0 cells. The KPNA2-vimentin-pErk complex was also up-regulated in the advanced stage compared with the early-stage lung adenocarcinoma tissues. Importantly, the levels of pErk as well as cell migration ability were significantly reduced in KPNA2-knockdown cells; however, migration was restored by treatment with pErk phosphatase inhibitors. Collectively, our results demonstrate the usefulness of a SILAC-based proteomic strategy for identifying invasiveness-associated KPNA2 protein complexes and provide new insight into the KPNA2-mediated modulation of cell migration.

Entities:  

Keywords:  Invasiveness; KPNA2; Lung cancer; Vimentin; pErk

Mesh:

Substances:

Year:  2015        PMID: 25728791     DOI: 10.1021/pr501097a

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  8 in total

1.  Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma.

Authors:  Chiung-Hung Hsu; Chia-Wei Hsu; Chuen Hsueh; Chih-Liang Wang; Yi-Cheng Wu; Chih-Ching Wu; Chin-Ching Liu; Jau-Song Yu; Yu-Sun Chang; Chia-Jung Yu
Journal:  Mol Cell Proteomics       Date:  2016-05-09       Impact factor: 5.911

2.  DHA-mediated regulation of lung cancer cell migration is not directly associated with Gelsolin or Vimentin expression.

Authors:  Mehboob Ali; Kathryn Heyob; Lynette K Rogers
Journal:  Life Sci       Date:  2016-05-05       Impact factor: 5.037

Review 3.  Quantitative proteomics in lung cancer.

Authors:  Chantal Hoi Yin Cheung; Hsueh-Fen Juan
Journal:  J Biomed Sci       Date:  2017-06-14       Impact factor: 8.410

4.  IRF1 Negatively Regulates Oncogenic KPNA2 Expression Under Growth Stimulation and Hypoxia in Lung Cancer Cells.

Authors:  Chih-Liang Wang; Chia-Jung Yu; Jie-Xin Huang; Yi-Cheng Wu; Ya-Yun Cheng
Journal:  Onco Targets Ther       Date:  2019-12-27       Impact factor: 4.147

5.  KPNA2 interaction with CBX8 contributes to the development and progression of bladder cancer by mediating the PRDM1/c-FOS pathway.

Authors:  Fanchang Zeng; Liumei Luo; Daoyuan Li; Juncheng Guo; Min Guo
Journal:  J Transl Med       Date:  2021-03-17       Impact factor: 5.531

6.  Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma.

Authors:  Wei-Chao Liao; Tsung-Jen Lin; Yu-Chin Liu; Yu-Shan Wei; Guan-Ying Chen; Hsiang-Pu Feng; Yi-Feng Chang; Hsin-Tzu Chang; Chih-Liang Wang; Hsinag-Cheng Chi; Chun-I Wang; Kwang-Huei Lin; Wei-Ting Ou Yang; Chia-Jung Yu
Journal:  Cancer Sci       Date:  2021-11-25       Impact factor: 6.716

Review 7.  Plectin in Cancer: From Biomarker to Therapeutic Target.

Authors:  Samantha M Perez; Lindsey T Brinton; Kimberly A Kelly
Journal:  Cells       Date:  2021-08-30       Impact factor: 6.600

8.  mTOR regulates proteasomal degradation and Dp1/E2F1- mediated transcription of KPNA2 in lung cancer cells.

Authors:  Chun-I Wang; Yan-Yu Chen; Chih-Liang Wang; Jau-Song Yu; Yu-Sun Chang; Chia-Jung Yu
Journal:  Oncotarget       Date:  2016-05-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.